Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 4/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 3/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | CA9 | Q16790 | 3/20 | 0.32 |
| ▸ | CRHR1 | P34998 | 1/20 | 0.32 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.31 |
| ▸ | CHRNA1 | P02708 | 1/20 | 0.31 |
| ▸ | CHRNG | P07510 | 1/20 | 0.31 |
| ▸ | CHRNB1 | P11230 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10135823 | 1.00 | PDK2 (0.33) | PDK2SIGMAR1MCL1ACMSDCA12 | |
| SCHEMBL10136054 | 1.00 | PDK2 (0.33) | PDK2SIGMAR1MCL1ACMSDCA12 | |
| SCHEMBL10135960 | 0.99 | SIGMAR1 (0.34) | PDK2SIGMAR1MCL1ACMSDCA12 | |
| SCHEMBL15138551 | 0.99 | SIGMAR1 (0.34) | PDK2SIGMAR1MCL1ACMSDCA12 | |
| SCHEMBL18650196 | 0.99 | PDK2 (0.34) | PDK2SIGMAR1MCL1ACMSDCA12 | |
| SCHEMBL10136087 | 0.98 | PDK2 (0.34) | PDK2SIGMAR1MCL1ACMSDCA12 | |
| SCHEMBL10135887 | 0.98 | PDK2 (0.34) | PDK2SIGMAR1MCL1ACMSDCA12 | |
| SCHEMBL10136074 | 0.98 | PDK2 (0.34) | PDK2SIGMAR1MCL1ACMSDCA12 | |
| SCHEMBL10135943 | 0.98 | SIGMAR1 (0.35) | PDK2SIGMAR1MCL1ACMSDCA12 | |
| SCHEMBL20707496 | 0.98 | SIGMAR1 (0.35) | PDK2SIGMAR1MCL1ACMSDCA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3010068-B1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO LTD (KR) | 2020-12-09 | — | — | EP | disclosed |
| US-20160111665-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-21 | — | — | US | disclosed |
| US-20160111665-A1 | ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-04-21 | — | — | US | disclosed |
| EP-3010068-A1 | ORGANIC LIGHT-EMITTING DEVICE | Samsung Display Co., Ltd. (KR) | 2016-04-20 | — | — | EP | disclosed |
| US-8883324-B2 | Aromatic amine derivative and organic electroluminescent device using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-8883324-B2 | Aromatic amine derivative and organic electroluminescent device using same | IDEMITSU KOSAN CO., LTD. (JP) | 2014-11-11 | — | — | US | disclosed |
| US-20120302793-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. | 2012-11-29 | — | — | US | disclosed |
| US-20120302793-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. | 2012-11-29 | — | — | US | disclosed |
| US-20120228594-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120228594-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20120184776-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| US-20120184776-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| US-20120112176-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20120112176-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20080303417-A1 | Aromatic Amine Derivative and Organic Electroluminescent Device Using Same | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
| US-20080303417-A1 | Aromatic Amine Derivative and Organic Electroluminescent Device Using Same | IDEMITSU KOSAN CO., LTD. (JP) | 2008-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120184776-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | EML4, DDC, ALKBH2 | PDK2 1007/4885SIGMAR1 2116/4885MCL1 3000/4885 |
| US-20120302793-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | NAT1, AFF1, AOC2 | PDK2 1693/4885SIGMAR1 468/4885MCL1 1804/4885 |
| US-20120112176-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | EML4, DDC, ALKBH2 | PDK2 1157/4885SIGMAR1 2138/4885MCL1 2922/4885 |
| US-20080303417-A1 | Aromatic Amine Derivative and Organic Electroluminescent Device Using Same | DDC, AOC2, ALKBH2 | PDK2 1389/4885SIGMAR1 1483/4885MCL1 2745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.